PARIS, July 29, 2016 /PRNewswire/ --
Sanofi, a global and diversified healthcare leader, reports results for the second quarter of 2016. CEO Olivier Brandicourt comments on the results.
Watch video interview and read transcript:
Topics covered in the interview include:
- Q2 highlights
- Diabetes
- Praluent(R)
- Dengvaxia(R)
- CHC
- R&D
- Outlook
About Sanofi
Sanofi, a global healthcare leader, discovers, develops and distributes therapeutic solutions focused on patients' needs. Sanofi is organized into five global business units: Diabetes and Cardiovascular, General Medicines and Emerging Markets, Sanofi Genzyme, Sanofi Pasteur and Merial. Sanofi is listed in Paris SAN and in New York SNY.
SOURCE Sanofi
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.